IFCT-0802
- Publications:
- Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial
- Randomized Phase II-III Study of Bevacizumab in Combination with Chemotherapy in Previously Untreated Extensive Small-Cell Lung Cancer: Results from the IFCT-0802 Trial
- Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et al
- Synopsis: IFCT-0802_Synopsis_211209.pdf